The role of C-reactive protein and ferritin in the diagnosis of HLH, adult-onset still’s disease, and COVID-19 cytokine storm.

The role of C-reactive protein and ferritin in the diagnosis of HLH, adult-onset still’s disease, and COVID-19 cytokine storm.

Publication date: Dec 28, 2024

Cytokine storm syndromes such as hemophagocytic lymphohistiocytosis (HLH), Adult-onset Still’s disease (AOSD), and COVID-19 cytokine storm (CCS) are characterized by markedly elevated inflammatory cytokines. However clinical measurement of serum cytokines is not widely available. This study examined the clinical utility of C-reactive protein (CRP) and ferritin, two inexpensive and widely available inflammatory markers, for distinguishing HLH from AOSD and CCS. This single centre retrospective study included 44 secondary HLH patients, 14 AOSD patients, and 13 CCS patients. Baseline CRP and ferritin measured within 72 h of diagnosis and before administration of corticosteroids or other anti-inflammatory therapies were analyzed. The median CRP in HLH patients was lower than AOSD (71 mg/L vs. 172 mg/L, p 

Open Access PDF

Concepts Keywords
71mg Adult
Inexpensive Aged
Lymphohistiocytosis Biomarkers
Serum Biomarkers
Storm C-Reactive Protein
C-Reactive Protein
COVID-19
Cytokine Release Syndrome
Diagnosis, Differential
Female
Ferritin
Ferritins
Ferritins
Hemophagocytic syndrome
HLH
Humans
Lymphohistiocytosis, Hemophagocytic
Male
Malignancy-associated HLH
Middle Aged
Retrospective Studies
SARS-CoV-2
Soluble interleukin-2 receptor
Still’s Disease, Adult-Onset
Young Adult

Semantics

Type Source Name
disease IDO role
disease MESH adult-onset still’s disease
disease MESH COVID-19
disease MESH cytokine storm
disease MESH syndromes
disease MESH hemophagocytic lymphohistiocytosis
disease MESH Malignancy
disease MESH morbidity
disease MESH Allergy
drug DRUGBANK Coenzyme M
drug DRUGBANK Etoposide
drug DRUGBANK Tocilizumab
drug DRUGBANK Baricitinib
disease MESH infection
disease MESH hyperferritinemia
disease MESH necrosis
disease MESH etiology
drug DRUGBANK Saquinavir
drug DRUGBANK Fibrinogen Human
drug DRUGBANK Anakinra
disease MESH viral infections
disease MESH bacterial infections
disease MESH critically ill
disease IDO blood
disease IDO immunosuppression
drug DRUGBANK Emapalumab
disease MESH Arthritis
disease MESH macrophage activation syndrome
disease MESH juvenile idiopathic arthritis
disease MESH Rheumatic Diseases
disease MESH sepsis
drug DRUGBANK Natural alpha interferon
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)